NEW YORK, Aug. 7, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investiga

SCOTTSDALE, Ariz., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”

Gainers Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 108.5% to $6.59 during Monday&#39

Urica Therapeutics, Inc. ("Urica" or the "Company"), a Fortress Biotech, Inc. (NASDA

MIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fort

Fortress Biotech is trading below its cash balance, offering deep value relative to its assets and r

Fortress Biotech now holds $256 million in cash and only $39 million in debt, establishing a fortres

SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Jou

MIAMI, May 18, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innov

ZYCUBO® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Th

Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 mill

Company to host conference call to discuss financial results and provide a corporate update on May 1

MIAMI, May 04, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innov

Payer access for Emrosi™ expanded from approximately 100 million commercial lives to over 150 millio

ZYCUBO® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Th

MIAMI, March 30, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its

Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024 Emrosi ™  generated

Company to host conference call to discuss financial results and provide a corporate update on March

Fortress Biotech, Inc. (NASDAQ: FBIO - Get Free Report)'s share price crossed above its 200-day movi

MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its

MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its

ATX-04 is a selective β2-adrenergic agonist with human proof-of-concept data demonstrating improved

Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a

  Tuesday saw 132 companies set new 52-week lows.

Companies Reporting Before The Bell • LightInTheBox Holding (NYSE:LITB) is estimated to report earn

  OnFriday, 143 stocks hit new 52-week lows.

  On Friday morning, 446 companies hit new 52-week lows.

  On Wednesday, 807 companies reached new 52-week lows.

  During Wednesday's trading, 435 companies set new 52-week lows.

  Wednesday's session saw 784 companies set new 52-week lows.

  During Tuesday's session, 454 stocks hit new 52-week lows.

    Tuesday's session saw 729 companies set new 52-week lows.

    On Monday, 524 stocks hit new 52-week lows.

    Wednesday's session saw 107 companies set new 52-week lows.

    During Tuesday's trading, 505 companies set new 52-week lows.

    On Friday, 313 companies hit new 52-week lows.

  During Friday's session, 445 companies made new 52-week lows.

    During Monday's morning session, 212 companies made new 52-week highs.

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) rose 73.6% to $9.65 in pre-market trading.

    During the morning session on Friday, 178 stocks hit new 52-week highs.

Gainers

Stocks That Hit 52-Week Lows On Monday

A Look At Benzinga Pro's Most-Searched Tickers For August 27, 2019

Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tuesday., August 27, 2019

50 Biggest Movers From Yesterday

30 Stocks Moving In Monday's Mid-Day Session

Stocks Which Set New 52-Week Low Yesterday, October 31st